LTIP418A - Antiatherosclerotic diaryl compounds - Google Patents

Antiatherosclerotic diaryl compounds

Info

Publication number
LTIP418A
LTIP418A LTIP418A LTIP418A LTIP418A LT IP418 A LTIP418 A LT IP418A LT IP418 A LTIP418 A LT IP418A LT IP418 A LTIP418 A LT IP418A LT IP418 A LTIP418 A LT IP418A
Authority
LT
Lithuania
Prior art keywords
antiatherosclerotic
diaryl compounds
compound
diaryl
compounds
Prior art date
Application number
LTIP418A
Inventor
William Paul Jckson
Clifford John Harris
John Gordon Dann
Kevin Julian O'connor
Robert Frederick Geoffre Booth
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of LTIP418A publication Critical patent/LTIP418A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/04Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms
    • C07C275/20Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms of an unsaturated carbon skeleton
    • C07C275/24Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing six-membered aromatic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00Carboxylic acid amides
    • C07C233/01Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/02Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • C07C233/04Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C233/07Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a six-membered aromatic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00Carboxylic acid amides
    • C07C233/01Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/02Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • C07C233/11Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to carbon atoms of an unsaturated carbon skeleton containing six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06Esters of carbamic acids
    • C07C271/40Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06Esters of carbamic acids
    • C07C271/40Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of six-membered aromatic rings
    • C07C271/42Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of six-membered aromatic rings with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/44Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of six-membered aromatic rings with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/28Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/28Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C275/30Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by halogen atoms, or by nitro or nitroso groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/28Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to cyano groups, e.g. cyanoguanidines, dicyandiamides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C327/00Thiocarboxylic acids
    • C07C327/38Amides of thiocarboxylic acids
    • C07C327/40Amides of thiocarboxylic acids having carbon atoms of thiocarboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C327/44Amides of thiocarboxylic acids having carbon atoms of thiocarboxamide groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of an unsaturated carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14The ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Steroid Compounds (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
  • Prostheses (AREA)
  • Eye Examination Apparatus (AREA)
  • Polarising Elements (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The present invention is concerned with the compound of formula (I)and salts, solvates and physiologically functional derivatives thereof, processes for the preparation of this compound, pharmaceutical formulations containing it and their use in medicine.
LTIP418A 1988-11-21 1993-03-15 Antiatherosclerotic diaryl compounds LTIP418A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888827152A GB8827152D0 (en) 1988-11-21 1988-11-21 Anti-atherosclerotic diaryl compounds

Publications (1)

Publication Number Publication Date
LTIP418A true LTIP418A (en) 1994-09-25

Family

ID=10647180

Family Applications (1)

Application Number Title Priority Date Filing Date
LTIP418A LTIP418A (en) 1988-11-21 1993-03-15 Antiatherosclerotic diaryl compounds

Country Status (27)

Country Link
EP (2) EP0450660B1 (en)
JP (1) JPH02188568A (en)
KR (1) KR900007790A (en)
AT (2) ATE78812T1 (en)
AU (1) AU638950B2 (en)
CA (1) CA2003395A1 (en)
CZ (1) CZ277693B6 (en)
DD (1) DD289263A5 (en)
DE (2) DE68902301T2 (en)
DK (1) DK581889A (en)
ES (2) ES2052028T3 (en)
FI (1) FI895520A0 (en)
GB (1) GB8827152D0 (en)
GR (1) GR3006091T3 (en)
HU (1) HU205342B (en)
IE (2) IE65411B1 (en)
IL (1) IL92358A (en)
LT (1) LTIP418A (en)
MX (1) MX9203417A (en)
MY (1) MY106247A (en)
NO (1) NO172233C (en)
NZ (1) NZ231448A (en)
PL (1) PL162010B1 (en)
PT (2) PT92354A (en)
RU (1) RU2036901C1 (en)
TW (1) TW213445B (en)
ZA (1) ZA898842B (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ229828A (en) * 1988-08-09 1992-03-26 Squibb & Sons Inc Aryl cyanoguanidine derivatives and pharmaceutical compositions
US5290814A (en) * 1988-11-21 1994-03-01 Burroughs Wellcome Co. Anti-atherosclerotic diaryl compounds
GB9020841D0 (en) * 1990-09-25 1990-11-07 Wellcome Found Anti-atherosclerotic aryl compounds
GB9027023D0 (en) * 1990-12-12 1991-01-30 Wellcome Found Anti-atherosclerotic aryl compounds
IL100915A (en) * 1991-02-19 1996-03-31 Erba Carlo Spa Disubstituted ureas and thioureas their preparation and pharmaceutical compositions containing them
US5364875A (en) * 1992-05-11 1994-11-15 The Du Pont Merck Pharmaceutical Company Imidazoles linked to bicyclic heterocyclic groups for the treatment of atherosclerosis
US5310748A (en) * 1992-05-11 1994-05-10 The Du Pont Merck Pharmaceutical Company Imidazoles for the treatment of atherosclerosis
CA2123728A1 (en) * 1993-05-21 1994-11-22 Noriyoshi Sueda Urea derivatives and their use as acat inhibitors
AU7006094A (en) * 1993-06-30 1995-01-24 Wellcome Foundation Limited, The Anti-atherosclerotic diaryl compounds
NZ264063A (en) * 1993-08-13 1995-11-27 Nihon Nohyaku Co Ltd N-(2-phenylpyrid-3-yl)- and n-(4-phenylpyrimidin-5-yl)-n'-phenylurea derivatives and pharmaceutical compositions
US5547966A (en) * 1993-10-07 1996-08-20 Bristol-Myers Squibb Company Aryl urea and related compounds
US5576335A (en) * 1994-02-01 1996-11-19 Nisshin Flour Milling Co., Ltd. Urea derivatives and their use as ACAT inhibitors
US5491152A (en) * 1994-03-23 1996-02-13 The Du Pont Merck Pharmaceutical Company Derivatives of cyclic ethers and sulfides for the treatment of atherosclerosis
AU3577995A (en) * 1994-10-04 1996-04-26 Fujisawa Pharmaceutical Co., Ltd. Urea derivatives and their use as acat-inhibitors
EP0742208A1 (en) * 1995-05-05 1996-11-13 Grelan Pharmaceutical Co., Ltd. 2-Ureido-benzamide derivatives
US5866609A (en) * 1996-08-09 1999-02-02 Ss Pharmaceutical Co., Ltd. Substituted vinylurea derivatives and medicine containing the same
FR2946345B1 (en) 2009-06-05 2011-05-20 Galderma Res & Dev NOVEL DIOXO-IMIDAZOLIDINE DERIVATIVES, ENZYME INHIBITORS SOAT-1, PHARMACEUTICAL AND COSMETIC COMPOSITIONS CONTAINING SAME
FR2946346B1 (en) 2009-06-05 2011-05-20 Galderma Res & Dev NOVEL DIOXO-IMIDAZOLIDINE DERIVATIVES, ENZYME INHIBITORS SOAT-1, PHARMACEUTICAL AND COSMETIC COMPOSITIONS CONTAINING SAME
FR2946342B1 (en) 2009-06-05 2011-06-24 Galderma Res & Dev NOVEL DIOXO-IMIDAZOLIDINE DERIVATIVES, ENZYME INHIBITORS SOAT-1, PHARMACEUTICAL AND COSMETIC COMPOSITIONS CONTAINING SAME
FR2946340B1 (en) 2009-06-05 2011-06-24 Galderma Res & Dev NOVEL N-PHENYL ACETAMIA, INHIBITORS OF ENZYME SOAT-1, PHARMACEUTICAL AND COSMETIC COMPOSITIONS CONTAINING SAME

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1382526A (en) * 1972-08-11 1975-02-05 Ici Ltd Morpholine derivatives
US4029786A (en) * 1972-08-11 1977-06-14 Imperial Chemical Industries Limited Morpholine derivatives for treating depression
CA1138451A (en) * 1979-04-03 1982-12-28 Ikuo Ueda 2-imidazoline derivatives, process for the preparation thereof and the pharmaceutical composition of the same
US4269829A (en) * 1979-06-18 1981-05-26 Rohm And Haas Company Method and composition for treating helminths containing O,O-dialkyl-N-(substituted phenyl)aminothiocarbonyl phosphoramidates
US4387106A (en) * 1982-01-26 1983-06-07 American Cyanamid Company Method of treating atherosclerosis with di(aralkyl)ureas and di(aralkyl)thioureas
JPS60500176A (en) * 1982-12-30 1985-02-07 ビ−チヤム グル−プ ピ−エルシ− Tetracyclic compound
US4603145A (en) * 1983-05-06 1986-07-29 American Cyanamid Company Antiatherosclerotic diphenyl alkanamides
US4716175A (en) * 1987-02-24 1987-12-29 Warner-Lambert Company Saturated fatty acid amides as inhibitors of acyl-CoA:cholesterol acyltransferase
ATE61574T1 (en) * 1987-07-02 1991-03-15 Warner Lambert Co N-((2,6-DISUBSTITUTED)-PHENYL>-UREA AND - CARBAMATE INHIBITORS OF ACYL-COENZYME A:CHOLESTEROL ACYLTRANSFERASE.

Also Published As

Publication number Publication date
MX9203417A (en) 1992-07-01
IE65411B1 (en) 1995-10-18
DD289263A5 (en) 1991-04-25
NO172233B (en) 1993-03-15
DE68902301T2 (en) 1993-02-25
IE893700L (en) 1990-05-21
GB8827152D0 (en) 1988-12-29
EP0370740A1 (en) 1990-05-30
PT92354A (en) 1990-05-31
NO172233C (en) 1993-06-23
PT101725A (en) 1996-01-31
DK581889D0 (en) 1989-11-20
ATE78812T1 (en) 1992-08-15
GR3006091T3 (en) 1993-06-21
ATE102604T1 (en) 1994-03-15
PL162010B1 (en) 1993-08-31
AU638950B2 (en) 1993-07-15
IE940341L (en) 1990-05-21
NO894616D0 (en) 1989-11-20
DE68913762D1 (en) 1994-04-14
EP0370740B1 (en) 1992-07-29
EP0450660B1 (en) 1994-03-09
KR900007790A (en) 1990-06-02
HUT52040A (en) 1990-06-28
AU4536389A (en) 1990-05-24
CA2003395A1 (en) 1990-05-21
NO894616L (en) 1990-05-22
DK581889A (en) 1990-05-22
IL92358A0 (en) 1990-07-26
JPH02188568A (en) 1990-07-24
CZ277693B6 (en) 1993-03-17
PT101725B (en) 1997-08-29
MY106247A (en) 1995-04-29
NZ231448A (en) 1992-03-26
DE68902301D1 (en) 1992-09-03
IL92358A (en) 1994-06-24
DE68913762T2 (en) 1994-06-23
ZA898842B (en) 1991-07-31
ES2052028T3 (en) 1994-07-01
CS655889A3 (en) 1992-11-18
TW213445B (en) 1993-09-21
ES2062610T3 (en) 1994-12-16
FI895520A0 (en) 1989-11-20
RU2036901C1 (en) 1995-06-09
EP0450660A1 (en) 1991-10-09
HU205342B (en) 1992-04-28

Similar Documents

Publication Publication Date Title
LTIP418A (en) Antiatherosclerotic diaryl compounds
PT83647A (en) Process for the preparation of novel pharmaceutical benzimidazole derivatives and of pharmaceutical compositions containing the same
MY101784A (en) Novel pharmacological compounds
ES2001094A6 (en) Guanine derivatives.
PH27446A (en) Compound with gastric acid inhibitory effect
TW261605B (en)
JO1519B1 (en) Novel compounds (Novel deravatives of Benzimidazoles active as anti-ulcer agents).